CSOP Hang Seng Biotech ETF (HKG:3174)
Hong Kong · Delayed Price · Currency is HKD 3.282
-0.102 (-3.01%)
Last updated: Mar 4, 2026, 3:24 PM HKT
48.91% (1Y)
| Assets | 886.49M |
| Expense Ratio | 1.50% |
| PE Ratio | 29.99 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +48.91% |
| Volume | 1,208,200 |
| Open | 3.368 |
| Previous Close | 3.384 |
| Day's Range | 3.252 - 3.370 |
| 52-Week Low | 1.942 |
| 52-Week High | 4.456 |
| Beta | 0.75 |
| Holdings | 31 |
| Inception Date | Jul 21, 2021 |
About 3174
CSOP Hang Seng Biotech ETF is an exchange-traded fund directly investing in companies. It prefers to invest in companies based out of Hong Kong. It primarily invests the healthcare- pharmaceutical and medical device companies.
Asset Class Equity
Category Health Care
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 3174
Provider CSOP
Index Tracked Hang Seng Biotech Index - HKD - Benchmark TR Net
Performance
3174 had a total return of 48.91% in the past year, including dividends. Since the fund's inception, the average annual return has been -18.01%.
Top 10 Holdings
70.65% of assets| Name | Symbol | Weight |
|---|---|---|
| WuXi Biologics (Cayman) Inc. | 2269 | 12.99% |
| BeOne Medicines AG | 6160 | 9.73% |
| Innovent Biologics, Inc. | 1801 | 9.27% |
| CSPC Pharmaceutical Group Limited | 1093 | 7.56% |
| Akeso, Inc. | 9926 | 7.56% |
| Sino Biopharmaceutical Limited | 1177 | 5.94% |
| WuXi AppTec Co., Ltd. | 2359 | 5.28% |
| Hansoh Pharmaceutical Group Company Limited | 3692 | 5.10% |
| 3SBio Inc. | 1530 | 3.93% |
| XtalPi Holdings Limited | 2228 | 3.28% |